Low-Level Light Therapy for Post-Training Recovery - Quick Reference Sheet

Low-Level Light Therapy for Post-Training Recovery

Created on 10/03/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

Low-level light therapy, a procedure that shines red or invisible infrared light onto muscles or the whole body, is an add-on tool for recovering from hard training. Effects are modest and inconsistent: possibly less soreness and slightly faster return of strength when applied before demanding sessions, though several careful independent studies found no benefit. Safety looks reassuring at recovery amounts, but benefit is less certain than its popularity suggests. (Full Review)

Protocol

Wavelength
655–950 nanometers
Red to near-infrared, from lasers, light-emitting diodes or both
Local dose per muscle group
20–60 joules small, 60–300 joules large
Up to 200 milliwatts per diode; one session per muscle group per workout
Timing
Before exercise
Within about 30 minutes of exercise; larger training gains than after
Time to effect
Recovery effects
24–96 hours
After a single session, where present
Sleep
14 nights
Nightly 30-minute whole-body red light in one small trial
Training adaptation
8–12 weeks
Strength gains only in untrained or moderately trained young men

Benefits

Contraindications
  • Active cancer at or near the treated area (theoretical)
  • Photodynamic drugs (verteporfin, porfimer, topical aminolevulinic acid) within the light-avoidance window, such as 5 days after verteporfin
  • Light-sensitivity disorders such as lupus or porphyria (theoretical)
  • Photosensitive epilepsy, for pulsed visible-light devices (theoretical)
  • Pregnancy, for light directed over the abdomen (theoretical; no human data)
  • Inability to wear wavelength-rated eye protection with Class IIIb or higher lasers
Key Interactions
  • Photosensitizing prescription drugs (tetracycline antibiotics such as doxycycline, fluoroquinolone antibiotics such as ciprofloxacin, amiodarone, hydrochlorothiazide, isotretinoin): Caution (theoretical)
  • Statins (atorvastatin, rosuvastatin): Monitor
  • Nonsteroidal anti-inflammatory drugs (ibuprofen, naproxen): Monitor (theoretical)
  • St John's wort (hypericin): Caution (theoretical)
  • High-dose antioxidant supplements (vitamin C 1 g or more, vitamin E): Monitor (theoretical)
  • Recovery supplements with additive soreness effects (tart cherry, curcumin, omega-3 fatty acids): Monitor (theoretical)
  • Cold therapy (ice packs): Caution

Risk & Side Effects

  • High:
  • Medium:
  • Low: Skin redness, blistering or darkening at high doses; eye injury from direct exposure
  • Speculative: Blunted training adaptation; stimulation of existing tumors; masked overload pain

Monitoring

Marker Target Why
Creatine kinase (CK) 10–120 mcg/L (standard reference range); varies by lab Marker expected to change (smaller post-exercise rise); safety check, as very high values signal dangerous muscle breakdown
Countermovement jump height (standing vertical jump with a quick dip) No established target; track change from own baseline at 24 and 48 hours post-workout Marker expected to change (faster return of power)
Strength test (static pull against fixed resistance, or heaviest load lifted for set repetitions) Faster return at 24–48 hours versus own baseline Defines success (faster return of strength)

Cadence: Baseline before starting; repeat after 2–4 weeks of use, then every 8–12 weeks, always after the same standard workout; skin check after each new device or dose increase

Qualitative Assessment

  • Soreness rating (0–10) at 24 and 48 hours after a standard workout
  • Perceived readiness to train and session effort ratings
  • Sleep quality, especially with evening whole-body protocols
  • Skin redness, darkening or blistering at treatment sites